Cochlear Limited (ASX: COH) - ETF Exposure

Current share price for COH : $137.760 0.05 (0.04%)⁺

Cochlear Limited (COH) is an ASX-listed company and is held by a number of exchange traded funds (ETFs). It has been the global leader in implantable hearing solutions for over 40 years, providing a range of implants and sound processor upgrades that deliver a lifetime of hearing outcomes.

COH General Information ⁺

ASX Code	COH
Website	http://www.cochlear.com
Industry/Sector	Health Care Equipment
Market Cap ($M)	9,009
COH Share Price	$137.760
Day High	$137.760
Day Low	$133.360
Last Close	$137.710
COH Share Price Movement	$0.05 ( 0.04% )

Prices as at 16:40, 27 Aug 2026

⁺Security prices are delayed by at least 20 minutes and are indicative only.

Already own an Australian ETF? You may already have meaningful exposure to COH

As a significant Australian company by market capitalisation, COH is held across 36 ETFs spanning strategies that include health care equipment exposure . Its weighting in those funds means performance can have an outsized influence - when COH moves, funds like AQLT, IMPQ, MVW, FAIR and ALFA that hold it can move with it.

For more concentrated exposure, ETFs such as AQLT (BetaShares Australian Quality ETF) allocate about 2.5% to COH , while the average exposure across all 36 ETFs that hold it is around 0.7% .

Top ETF holdings

BetaShares Australian Quality ETF (AQLT) ~ 2.5%
eInvest Better Future (Managed Fund) (IMPQ) ~ 2%
VanEck Australian Equal Weight ETF (MVW) ~ 1.7%
BetaShares Australian Sustainability Leaders ETF (FAIR) ~ 1.6%
Vaneck Australian Long Short Complex ETF (ALFA) ~ 1.6%

Last updated: ETF data and holdings as at 26 August 2026

Own COH directly or through an ETF?

How does holding Cochlear Limited (COH) shares directly compare to ETFs that include it?

	COH Direct	AQLT ASX	IMPQ ASX	MVW ASX	FAIR ASX	ALFA ASX
Holdings	1 company	46 holdings	41 holdings	74 holdings	83 holdings	105 holdings
COH Weight	100%	2.5%	2%	1.7%	1.6%	1.6%
Diversification	Single Stock	Broad	Broad	Broad	Broad	Broad
Annual Cost	Brokerage only	0.35% p.a.	0.89% p.a.	0.35% p.a.	0.49% p.a.	0.39% p.a.
Approx. Yield	2.8%	4.06%	2.16%	3.34%	3.06%	0.87%
Star Ratings	-

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not COH's direct yield. Annual cost uses each ETF's MER.

COH Exposure on $10,000 investment

How a $10,000 investment in Cochlear Limited (COH) one week ago compares with ETFs that hold it.

Security	Investment type	Current price	7-day price movement	Dollar change	Value today
Cochlear Limited (COH)	Direct share	$137.760	0.34%	+$34	$10,034
BetaShares Australian Quality ETF (AQLT)	Equity - Australia Strategy	$35.430	-1.17%	-$117	$9,883
eInvest Better Future (Managed Fund) (IMPQ)	Equity - Australia Small/Mid Cap	$4.160	-4.37%	-$437	$9,563
VanEck Australian Equal Weight ETF (MVW)	Equity - Australia	$39.200	-0.36%	-$36	$9,964
BetaShares Australian Sustainability Leaders ETF (FAIR)	Equity - Australia Strategy	$18.920	-1.20%	-$120	$9,880
Vaneck Australian Long Short Complex ETF (ALFA)	Equity - Australia Strategy	$23.030	1.86%	+$186	$10,186

Assumes $10,000 invested 7 days ago. Figures are based on price movement only and exclude distributions, fees and brokerage.

Cochlear Limited (COH) ETFs

36 ETFs hold Cochlear Limited (COH).

ETF	COH Weight	MER	Yield
BetaShares Australian Quality ETF (AQLT)	2.5%	0.35%	4.06%
eInvest Better Future (Managed Fund) (IMPQ)	2%	0.89%	2.16%
VanEck Australian Equal Weight ETF (MVW)	1.7%	0.35%	3.34%
BetaShares Australian Sustainability Leaders ETF (FAIR)	1.6%	0.49%	3.06%
Vaneck Australian Long Short Complex ETF (ALFA)	1.6%	0.39%	0.87%
Australian Ethical High Conviction Fund - Active ETF (AEAE)	1.3%	0.69%	-
VanEck MSCI Australian Sustainable Equity ETF (GRNV)	1.2%	0.35%	3.56%
Fidelity Australian High Conviction Active ETF (FHCO)	1.2%	0.85%	31.22%
Global X Australia ex Financials & Resources ETF (OZXX)	1.2%	0.25%	5.08%
Betashares Australian Ex-20 Portfolio Diversifier ETF (EX20)	0.8%	0.2%	2.72%

View all 36 ETFs

Cochlear Limited (COH) Upcoming Dividends & Yields

Distribution Type	Dividend	Franking	Ex-dividend date	Payment date	Current Price⁺	Price 7D Avg	Dividend Yield
HFResult	$1.30	85%	21 Sep 2026	14 Oct 2026	-	-	-
Result	$2.15	85%	19 Mar 2026	13 Apr 2026	-	-	-
HFResult	$2.15	85%	18 Sep 2025	13 Oct 2025	-	-	-

See all dividends from Cochlear Limited (COH) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Cochlear Limited (COH) price-sensitive announcements

COH - FY26 Result - Presentation

Cochlear Limited reported a 2% increase in constant currency sales revenue for FY26, achie

Cochlear Limited (COH)
18 Aug 2026 | 7:50 AM

COH - FY26 Result - ASX & Media Release

Cochlear Limited's FY26 results showed an underlying net profit of $322 million, with chal

Cochlear Limited (COH)
18 Aug 2026 | 7:30 AM

COH - Appendix 4E

The preliminary final report for Cochlear Limited as of 30 June 2026 shows a slight decrea

Cochlear Limited (COH)
18 Aug 2026 | 7:30 AM

COH - Trading update and reduction to FY26 earnings guidance

Cochlear Limited has issued a trading update and revised its FY26 earnings guidance downwa

Cochlear Limited (COH)
22 Apr 2026 | 8:20 AM

Cochlear Limited (COH) Recent ASX Announcements

Company	Sector	Market Cap ($m)	Headline	Release date/time⁺	Price at release⁺	Current price⁺	Gain/Loss
Cochlear Limited (COH) ORDINARY FULLY PAID	Health Care	$9,009	Becoming a substantial holder	27 Aug 2026 4:37PM	$137.760	$137.760	fallen by 0%
Cochlear Limited (COH) ORDINARY FULLY PAID	Health Care	$9,009	Appendix 3Y - Michael del Prado	27 Aug 2026 9:05AM	$137.710	$137.760	risen by 0.04%
Cochlear Limited (COH) ORDINARY FULLY PAID	Health Care	$9,009	Appendix 3Y - Caroline Clarke	27 Aug 2026 9:04AM	$137.710	$137.760	risen by 0.04%
Cochlear Limited (COH) ORDINARY FULLY PAID	Health Care	$9,009	Change in substantial holding	26 Aug 2026 6:14PM	$137.710	$137.760	risen by 0.04%
Cochlear Limited (COH) ORDINARY FULLY PAID	Health Care	$9,009	Change in substantial holding	26 Aug 2026 5:37PM	$137.710	$137.760	risen by 0.04%
Cochlear Limited (COH) ORDINARY FULLY PAID	Health Care	$9,009	Appendix 3Y - Michael Daniell	25 Aug 2026 8:39AM	$135.770	$137.760	risen by 1.47%

COH Financial Summary

Year to Jun	NPAT	EPS	EPS chg (%)	PER	DPS	Yield (%)	Franking (%)
2026F	$462.53	$701.75	10.90%	43.96	490.00	1.59%	100.0%
2025F	$417.22	$633.00	7.60%	48.74	440.00	1.43%	100.0%
2024A	$386.60	$588.25	27.00%	48.98	410.00	1.42%	75.1%

COH Peer Comparison

Company	Mkt Cap	EPS Growth (%)			P/E (%)			Dividend Yield (%)
Company	Mkt Cap	2024 A	2025 F	2026 F	2024 A	2025 F	2026 F	2024 A	2025 F	2026 F
Cochlear Limited (COH)	$9,015M	-0.3136	0.2540	0.0785	33.5581	26.7609	24.8132	2.50%	2.60%	2.83%
Fisher & Paykel Healthcare Corporation Limited (FPH)	$21,871M	0.1388	0.1650	0.1748	56.3133	48.3385	41.1446	1.16%	1.26%	1.42%
ResMed Inc. (RMD)	$19,225M	9.5922	0.0985	0.0885	21.1090	19.2162	17.6531	1.10%	1.20%	1.29%

COH Market Comparison

	Earnings	P/E Ratio	P/B Ratio	P/E Growth
Company	0.94	32.20	5.17	1.98
Market	0.64	17.50	1.66	1.36
Sector	0.66	20.00	1.68	3.51

COH Directors

Name	Position	Start Date
Ms Christine Frances McLoughlin	Non-Executive Director	1 Nov 2020
Sir Michael Grenfell Daniell	Non-Executive Director	1 Jan 2020
Ms Karen Lee Collett Penrose	Non-Executive Director	1 Jul 2022
Mr Richard John Freudenstein	Non-Executive Director	25 Aug 2025
Professor Bruce Gregory Robinson AC	Non-Executive Director	13 Dec 2016
Mr Michael del Prado	Non-Executive Director	1 Jan 2022
Ms Caroline Louise Clarke	Non-Executive Director	2 Sep 2024
Ms Catriona Alison Deans	Non-Executive Director, Non-Executive Chairman	1 Jan 2015
Mr Dig Howitt	President, Chief Executive Officer, Managing Director	14 Nov 2017

Cochlear Limited (COH) Changes in Directors' Interest & Trades

Date of change	Director	Buy/Sell	Security Type	Qty	Trade Price	Value
24 Aug 2026	DEL PRADO, Michael	Buy	Direct Shares	412	$96.750	$39,861.000
24 Aug 2026	CLARKE, Caroline	Buy	Direct Shares	257	$136.000	$34,952.000
24 Aug 2026	CLARKE, Caroline	Buy	Direct Shares	444	$134.470	$59,704.680

See all changes in directors' interest & trades for Cochlear Limited (COH) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

COH Management

Name	Position
Sarah Thom	CFO
Jan Janssen	Chief Technology Officer
Kristy Jo	Company Secretary
Rob McGrory	Company Secretary

COH Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Cochlear Limited (COH). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding	Name
4,692,142 (7.20%)	State Street Corporation and subsidiaries
4,352,496 (6.70%)	BlackRock, Inc
3,854,464 (5.90%)	The Vanguard Group,Inc

COH Calendar of Events

Date	Event
17 August 2027	Report (Annual)
17 August 2027	Report (Prelim)
12 February 2027	Report (Interim)
14 October 2026	Div Pay Date
22 September 2026	Books Close
21 September 2026	Div Ex Date

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.

What our members say about us